Sandoz Resolves Takeda Patent Dispute Over Actos
Sandoz Inc. has settled in Takeda Pharmaceutical Co. Ltd.'s patent infringement litigation over the generics maker's effort to sell its own versions of diabetes treatments Actos and Actoplus Met, leaving only...To view the full article, register now.
Already a subscriber? Click here to view full article